Modern Unawareness - March of Dimes
There is a burgeoning interest in Thalidomide as a "new" therapeutic agent for a broad spectrum of disorders. Unfortunately, there is a concurrent lack of knowledge by the younger generation of its teratogenic properties.
According to a representative from the FDA's Marketing Practices and
Communications Branch, "we found that two thirds of those under 45 years
didn't recognize the word (thalidomide) ...". Perhaps, the March of Dimes
can devise a campaign for Thalidomide akin to educational programs about
Folic Acid's role in preventing spina bifida (taken in part from a JAMA
report "Thalidomide Back Under Strict Control" in Medical News & Perspectives,
October 8, 1997).